Finance

Lists
ONCOZ:STO
Oncozenge AB
SEK 3.53
+0.86%
(+0.030) 1D
Sep 8, 5:29:36 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCOZ...
Open
SEK 3.45
High
SEK 3.69
Low
SEK 3.45
Mkt. cap
91.56M
Avg. vol.
54.54K
Volume
49.54K
52-wk high
SEK 8.58
52-wk low
SEK 3.26
EPS
-SEK 1.76
Shares outstanding
14.82M
No. of employees
1
Open
SEK 3.45
High
SEK 3.69
Low
SEK 3.45
Mkt. cap
91.56M
Avg. vol.
54.54K
Volume
49.54K
52-wk high
SEK 8.58
52-wk low
SEK 3.26
EPS
-SEK 1.76
Shares outstanding
14.82M
No. of employees
1
About Oncozenge AB
CEOPaul de Potocki
Employees1
Founded2020
Headquarters-
SectorPharmaceutical industry
Websiteoncozenge.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.00K
1.00K
-
5.96M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.48M
9.75M
6.80M
11.25M
Operating expense
3.48M
9.75M
6.80M
11.40M
Total operating expenses
3.48M
9.75M
6.80M
11.40M
Operating income
-3.48M
-9.75M
-6.80M
-5.44M
Other non operating income
-
-
-
-
EBT including unusual items
-3.49M
-9.89M
-7.13M
-5.67M
EBT excluding unusual items
-3.49M
-9.89M
-7.13M
-5.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2.00K
-
2.00K
150.00K
Net income
-3.49M
-9.89M
-7.13M
-5.67M
Net profit margin
-174,550.00%
-988,600.00%
-
-95.04%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
15.00K
-
-
Interest expense
-13.00K
-154.00K
-330.00K
-226.00K
Net interest expenses
-12.00K
-139.00K
-330.00K
-226.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps